A Low Affinity Vasopressin V₂-Receptor in Inherited Nephrogenic Diabetes Insipidus

References

• Jard S. Vasopressin receptors. Frontiers of Hormone Research 13, P. Czernichov, A. G. Robinson. Karger, Basel 1985; 89
   Google Scholar
• Williams R. H., Henry C. Nephrogenic diabetes insipidus: transmitted by females and appearing during infancy in males. Ann. Int. Med. 1947; 27: 84–95
   PubMed Web of Science ®Google Scholar
• Bode H. H., Crawford J. D. Nephrogenic diabetes insipidus in North America – the Hopewell hypothesis. N. Engl. J. Med. 1969; 280: 750–754
   Google Scholar
• Moses A. M., Coulson B. B. Absence of overlapping resistance to vasopressin and parathyroid hormone in patients with nephrogenic diabetes insipidus and pseudohypopara-thyroidism. J. Clin. Endocrinol. Metab. 1982; 55: 699–702
   PubMed Web of Science ®Google Scholar
• Culpepper R. M., Hebert S. C., Andreoli T. E. Nephrogenic diabetes insipidus. The Metabolic Basis of Inherited Disease, J. B. Sanbury, J. B. Wyngaarden, D. S. Frederickson, J. L. Goldstein, M. S. Brown. McGraw-Hill, New York 1983; 1867–1882
   Google Scholar
• Bichet D. G., Razi M., Arthus M.-F., Lonergan M., Tittley P., Smiley R. K., Rock G., Hirsch D. J. Epinephrine and dDAVP administration in patients with congenital nephrogenic diabetes insipidus. Kidney Internat 1989; 36: 859–866
   Google Scholar
• Jackson B. A., Edwards R. M., Valtin H., Dousa T. P. Cellular action of vasopressin in medullary tubules of mice with hereditary nephrogenic diabetes insipidus. J. Clin. Invest. 1980; 66: 110–122
   Google Scholar
• Kusano E., Yusufi A., Murayama N., Braun-Werness I., Dousa T. P. Dynamics of nucleotides in distal nephron of mice with nephrogenic diabetes insipidus, Am. J. Physiol. 1986; 260: F151–F158
   Google Scholar
• Proesmans W., Eggermont E., van der Schneren-Lodeweydex M., Tiddens H., Eckels R. The effect of exogenous 3′:5′ adenosine monophosphate on urinary output in children with vasopressin resistant diabetes insipidus, Pediatr. Res. 1975; 9: 509–512
   Google Scholar
• Grünbaum E. G., Rascher W., Fahrenholz F., Luzius H., Jans D. A., Moritz A., Hecht W. Genetisch bedingter Diabetes Insipidus renalis beim Hund. 35th Annual Meeting, Deutsche Veterinärmedizinische Gesellschaft DVG, Fachgeruppe Kleintierkrankheiten (ed. DVG). 1990; 126–152, DVG, Gießen, FRG
   Google Scholar
• Lage A. L. Nephrogenic diabetes insipidus in a dog. J. Am. Vet. Med. Ass. 1973; 163: 251–253
   Google Scholar
• Moses A. M., Scheinman S. J., Schroeder E. T. Antidiuretic and PGE2 responses to AVP and dDAVP in subjects with central and nephrogenic diabetes insipidus. Am. J. Physiol. 1985; 248: F354–F359
   Google Scholar
• Orr F. R., Filipich R. L. Studies with angiotensin in nephrogenic diabetes insipidus. Can. Med. Assoc. J. 1967; 97: 841–845
   Google Scholar
• Grzonka Z., Kasprzykowski F., Kojro E., Darlak K., Melin P., Fahrenholz F., Crause P., Boer R. Arginine-vasopressin analogues with high antidiuretic/vasopressor selectivity. Synthesis, biological activity, and receptor binding affinity of arginine-vasopressin analogues with substitutions in positions 1,2,4,7, and 8. J. Med. Chem. 1985; 29: 96–99
   Google Scholar
• Iyengar R., Mailman D. S., Sachs G. Purification of distinct plasma membranes from canine renal medulla. Am. J. Physiol. 1978; 234: F247–F254
   Google Scholar
• Fahrenholz F., Boer R., Crause P., Fritsch G., Grzonka Z. Interactions of vasopressin agonists and antagonists with membrane receptors. Eur. J. Pharmacol. 1984; 100: 47–54
   PubMed Web of Science ®Google Scholar
• Tovey K. C., Oldham K. G., Whelan J. A. M. A simple direct assay for cyclic AMP in plasma and other biological samples using an improved competitive protein technique, Clin. Chim. Acta. 1974; 56: 21–234
   Google Scholar
• Rascher W., Lang R. E., Unger Th., Ganten D., Gross F. Vasopressin in brain of spontaneously hypertensive rats. Am. J. Physiol. 1982; 242: H496–H499
   PubMed Web of Science ®Google Scholar
• Schwarz-Porsche D. Small animal practice. Current veterinary therapy VII, R. W. Kirk. W. B. Saunders Co., Philadelphia 1980; 1005–1011
   Google Scholar
• Weitzman R. E., Fisher D. A. Arginine vasopressin metabolism in dogs I. Evidence for a receptor-mediated mechanism. Am. J. Physiol. 1978; 235: E591–E597
   Google Scholar
• Wilson K. C., Weitzman R. E., Fisher D. A. Arginine vasopressin metabolism in dogs II. Modeling and system analysis. Am. J. Physiol. 1978; 235: E598–E605
   Google Scholar
• Keeler R., Sato A. K., Claybaugh J. R., Wilson N. Effect of V2 antagonist on clearance of arginine vasopressin by isolated perfused rat kidneys. Am. J. Physiol. 1991; 30: R665–R669
   Google Scholar
• Knoers N., van der Heyden H., van Oost B. A., Ropers H. H., Monnens L., Willems J. Nephrogenic diabetes insipidus: close linkage with markers from the distal long arm of the human X chromosome. Human. Genet. 1988; 80: 31–38
   Google Scholar
• Jans D. A., van Oost B. A., Ropers H. H., Fahrenholz F. Derivatives of somatic cell hybrids which carry the human gene locus for nephrogenic diabetes insipidus (NDI) express functional vasopressin renal V2–type receptors. J. Biol. Chem. 1990; 265: 15379–15382
   Google Scholar
• Moses A. M., Moses L. K., Notman D. D., Springer J. Antidiuretic response to injected desmopressin, alone and with indomethacin. J. Clin. Endocrinol. Metab. 1982; 52: 910–913
   Google Scholar